Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Morphosys Ag ADR (NQ: MOR )

7.050 +0.200 (+2.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,327,915
Open 6.630
Bid (Size) 7.060 (1)
Ask (Size) 7.190 (10)
Prev. Close 6.850
Today's Range 6.600 - 7.200
52wk Range 3.170 - 8.670
Shares Outstanding 32,890,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sprinklr Reports Downbeat Earnings, Joins Chewy, GameStop And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded mixed this morning, with the Dow Jones futures falling around 70 points on Thursday. Shares of Sprinklr, Inc. (NYSE: CXM) shares fell sharply in pre-market trading following... 
Via Benzinga
Topics Stocks
Exposures US Equities
Dell Reports Mixed Q3 Results, Joins Marvell Technology, Super Micro Computer And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining more than 80 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
+98.31%
+98.31%
1 Month
-10.08%
-10.08%
3 Month
-11.54%
-11.54%
6 Month
-0.28%
-0.28%
1 Year
+65.88%
+65.88%

More News

Read More
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Expert Ratings for MorphoSys
Via Benzinga
Recap: MorphoSys Q3 Earnings
Via Benzinga
MorphoSys's Earnings Outlook
Via Benzinga
Invitation to MorphoSys' Third Quarter and First Nine Months 2023 Financial Results Conference Call on November 16, 2023
Via ACCESSWIRE
Zscaler Posts Q1 Results, Joins argenx, Cool Company And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
DLocal Posts Weak Results, Joins HP, Autodesk And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Origin Materials Layoffs 2023: What to Know About the Latest ORGN Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Why Is Cancer Focused MorphoSys Stock Trading Lower Today?
Via Benzinga
FSR Stock Alert: Fisker Receives Non-Compliance Notice From NYSE
Via InvestorPlace
Why Is MorphoSys (MOR) Stock Down 20% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
AVITA Medical Cuts Revenue Forecast, Joins iQIYI, Trip.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Ad hoc: MorphoSys' Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
Via ACCESSWIRE
MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
From MorphoSys AG
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
From MorphoSys AG
Via Business Wire
MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
Via ACCESSWIRE
MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.